Fig. 1 · Structure

Documents & Downloads

Pimecrolimus

Cat. No. A10732 CAS 137071-32-0
Pimecrolimus is a natural ascomycin macrolactam that binds to macrophilin-12 (FKBP-12) and inhibits calcineurin as well as prolyl isomerase (rotamase).

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Pimecrolimus Research Summary

This section summarizes 1 in vitro study of Pimecrolimus from 1 published reference. In vitro models include neurons derived from KhES-1.

Pimecrolimus In Vitro Studies

Pimecrolimus was evaluated in neurons derived from KhES-1, with DMSO-treated K1 neurons as the control. Treatment inhibited Aβ in a dose-dependent manner without toxicity to K1-derived neurons at concentrations below 10 μM. [1]

Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.

Pimecrolimus inhibits neuronal Aβ

Cell-based study · neurons derived from KhES-1 [1]

Pimecrolimus: inhibit Aβ in a dose-dependent manner without toxicity to the K1-derived neurons at concentrations of less than 10 μM.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
Aβ40Reported result inhibit Aβ in a dose-dependent manner without toxicity to the K1-derived neurons at concentrations of less than 10 μM[1]

Literature-Reported Treatment Conditions

Treatment concentration
0, 0.001, 0.01, 0.1, 1, and 10 μM
Method
cultured in neuron maintenance medium
Vehicle
DMSO
Co-treatment
Other interventions in this design: LDN-193189 100 nM; SB431542 1 μM; cytosine arabinoside (AraC) 1 μM; brain-derived neurotrophic factor 10 ng/ml; glial cell-derived neurotrophic factor 10 ng/ ml; neurotrophin-3 10 ng/ml; beta-nerve growth factor 100 ng/mL. Compound effect isolated by the comparison: DMSO-treated PS1-G378E or K1 neurons.
Reported limits
Not stated in the sentences used: schedule.
Methods and source locations

Compound reported in the paper: Pimecrolimus

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

Results > The screening of Aβ40 inhibitors using AD model neurons (S22); Methods > Cell culture and neural differentiation (S44, S45); Methods > Chemical screening (S48, S59); Figure 2 legend (S94, S97, S100); Figure 3 legend (S101)

Aβ40: Aβ40; comparator: DMSO-treated K1 neurons — Results > The screening of Aβ40 inhibitors using AD model neurons (S22); Figure 2 legend (S97)

Specifications

Manufacturer Adooq Bioscience
CAS Number 137071-32-0
Formula C43H68ClNO11
Molecular Weight 810.5
Synonyms Elidel; SDZ-ASM-981
SMILES
CC[C@@H]1/C=C(\C[C@@H](C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC1=O)O)C)/C(=C/[C@@H]4CC[C@@H]([C@@H](C4)OC)Cl)/C)O)C)OC)OC)C)/C

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO 94 mg/mL (115.98 mM)
Water Insoluble
Ethanol 94 mg/mL (115.98 mM)

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Pimecrolimus Research References

  1. [1] Nishioka H, Tooi N, Isobe T, et al. BMS-708163 and Nilotinib restore synaptic dysfunction in human embryonic stem cell-derived Alzheimer's disease models. Sci Rep (2016). PMID: 27641902 DOI: 10.1038/srep33427 Source material

Added to your cart

View Cart Checkout
Loading...